Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-25 @ 5:01 PM
NCT ID:
NCT03987503
Pre Assignment Details:
Of the 492 screened for hepatitis C infection, 403 were excluded. Reasons for exclusion included: 3 untreated HIV, 246 anti-HCV negative, 102 anti-HCV positive and RNA negative, 18 unsuccessful blood draw, 12 other clinical criteria (treatment experience, untreated HIV, HBsAg positivity, or decompensated cirrhosis), and 22 did not return for RNA results. Of the 89 participants eligible for treatment, 87 accepted and 2 declined treatment. All 87 received "at Point-of-Diagnosis HCV Treatment".
Recruitment Details:
Between July 1 2020 and October 31, 2021 street-outreach recruitment targeted people experiencing homelessness and injecting drugs. Eligibility included being 18 years or older and reporting either lifetime injection drug use or having a blood transfusion in or before 1992.
Study:
NCT03987503
Study Brief:
Results Section:
NCT03987503